Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
Submitted by
admin
on May 18, 2015 - 9:40pm
Source:
Fierce Pharma
News Tags:
FDA
SGLT2 inhibitor
AstraZeneca
JNJ
Eli Lilly
Merck
diabetes
Headline:
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
Do Not Allow Advertisers to Use My Personal information
